Biotech Layoff Tracker 2024. And what’s going to move markets in 2024? The sankey diagram below highlights the web of factors driving the 2024 biotech layoffs for select companies, from operational changes to clinical failures.

More recently, two months after acquiring san diego biotech mirati therapeutics in january 2024, in a deal worth $4.8 billion, bristol myers squibb said in a worker adjustment. Biopharma layoffs rose 57% last year compared to 2022, with 187 industry workforce reductions in 2023 compared to 119, according to an analysis of fierce biotech data.